New Data Show ACTOS (pioglitazone HCl) Halted Progression Of Atherosclerosis As Indicated By CIMT
Sat, 18 Nov 2006 08:00 AM EST
... On 13-Nov-2006 researchers presented data showing that ACTOS® (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid intima-media thickness (CIMT) in patients with type 2 diabetes. [click link for full article] ...
Related Topics
- Pioglitazone
- Atherosclerosis
- Data & Statistics
- Data Analysis
- National Data
- Mining
- Arteriosclerosis/Atherosclerosis
- Levocarnitine Oral
- Diltiazem
- Tizanidine
- Slide Show: Types of Dermatitis
- Logging
- Chemical Safety
- Visualization
- Influenza Surveillance Data
- Hospital Data / Inpatient Care
- Universal Data Collection Updates
- Vaccine Safety: Data-Sharing Process
- Safety
- Hydroxyzine

Not Signed In -


